GLP-1 RECEPTOR AGONIST

LIRATIDE™

LIRAGLUTIDE · 10 MG

Liratide™ is liraglutide, an acylated analogue of human GLP-1 with 97% homology to the native hormone — engineered for protracted receptor activation. Supplied as lyophilised powder in vials of 10 mg, packed 3 vials per foil sachet for wholesale distribution.

RESEARCH KEYPOINT  Research found the benefit of liraglutide in helping reduce body weight by a mean of 8.4 kg with improved glycaemic control in the 56-week SCALE phase 3 trial.

REQUEST QUOTATION VIEW SPECIFICATIONS
FOR EXPORT ONLY FOR RESEARCH AND ANALYTICS ONLY
Liratide Liratide liraglutide 10 mg sachet label, 3 vials per sachet

ABOUT LIRATIDE

The GLP-1 analogue liraglutide

Liraglutide is a 31-amino-acid acylated analogue of human glucagon-like peptide-1 (GLP-1), modified with a C16 fatty-acid chain that enables albumin binding and a plasma half-life of around 13 hours — activating the GLP-1 receptor, it enhances glucose-dependent insulin secretion, suppresses glucagon and slows gastric emptying.

Research spans incretin physiology, appetite regulation and energy balance, and comparative pharmacology across the GLP-1 receptor agonist class. Liratide™ supplies liraglutide as a defined, batch-documented reference material with identity and purity verified on every lot.

31AA

ACYLATED GLP-1 ANALOGUE

10 MG

PER VIAL

2–8°C

COLD CHAIN

DNA double helix illustration representing peptide analogue research

RESEARCH BACKGROUND

The GLP-1 agonist proven at phase 3 scale

In the 56-week SCALE Obesity and Prediabetes trial published in the New England Journal of Medicine, 3.0 mg daily liraglutide produced a mean weight loss of 8.4 kg versus 2.8 kg with placebo among 3,731 participants, alongside improved glycaemic and cardiometabolic markers.

Liraglutide became one of the defining molecules of the GLP-1 era — studied across diabetes, obesity and cardiovascular outcomes — and it remains a reference agonist for incretin-receptor pharmacology and comparative studies within the class.

PRIMARY REFERENCE

Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11–22.

ClinicalTrials.gov: NCT01272219

DOI: 10.1056/NEJMOA1411892

Reference provided for scientific context only. Liratide™ is analytical grade, for research and analytics only, and is not a medicinal product or dietary supplement. CoreyPauling is not affiliated with the cited authors.

PRODUCT SPECIFICATIONS

Liratide™ at a glance

Product name Liratide™
Active substance Liraglutide — acylated GLP-1 receptor agonist, 97% homology to native GLP-1
Strength 10 mg per vial
Form Lyophilised powder for reconstitution
Presentation Multi-dose glass vial
Pack size 3 vials per foil sachet
Origin Acylated GLP-1 analogue, produced synthetically
Storage Store cold at 2–8°C; stable refrigerated for full shelf life, near-stable over 90 days at room temperature
Intended use Analytical grade · For research and analytics only · For export only
Documentation Batch-specific Certificate of Analysis
RESEARCH KEYPOINT Research found the benefit of liraglutide in helping achieve a mean 8.4 kg weight loss over 56 weeks versus 2.8 kg with placebo, based on the SCALE phase 3 trial in the New England Journal of Medicine (Pi-Sunyer et al., 2015).

OUR TECHNOLOGY

Pressurized Dark-Room Fragmented Lyophilization

Liratide™ is lyophilised using CoreyPauling's proprietary Pressurized Dark-Room Fragmented Lyophilization process, which protects the peptide from light and oxidative stress during freeze-drying — critical for an acylated peptide whose protracted action depends on its intact fatty-acid side chain. The result is stability that conventional lyophilisates cannot match.

90+ days

Near-stable at room temperature

The lyophilised powder remains almost fully stable for over 90 days at room temperature — forgiving of transit delays and customs holds without loss of integrity.

3 years

Stable in cold storage

Stored cold at 2–8°C, Liratide™ retains full stability for the shelf life stated on every label, from the date of manufacture.

Liratide™ is analytical grade only. CoreyPauling does not encourage or support its use in humans or veterinary applications.

QUALITY & MANUFACTURING

Every batch documented

STD

International standards

Manufactured under internationally recognised quality standards with controlled environments and validated processes at every production step.

HPLC

Analytical verification

Identity, purity and content are verified by HPLC and complementary analytical methods before any batch is released.

LOT

Full traceability

Lot, manufacturing and expiry data are printed on every sachet and vial, tied to batch records and the Certificate of Analysis.

STORAGE & HANDLING

Cold chain, door to door

Store cold at 2–8°C

Keep refrigerated for full shelf life. Do not freeze. Protect vials from light and keep them in the original sachet until use; brief room-temperature excursions are tolerated thanks to our lyophilization process.

Insulated export shipping

Wholesale consignments ship in insulated packaging with cooling elements and temperature indicators, with export documentation prepared per destination.

FAQ

Frequently Asked Questions

Liratide™ is available exclusively through authorized retailers and distributors. Contact our wholesale team to be directed to an authorized retailer in your region.

No. CoreyPauling supplies wholesale quantities to distributors and authorized retailers only.

MOQ depends on destination and packaging configuration. Standard wholesale units are sachets of 3 vials; contact us with your required volume for tiered pricing.

Yes. Every batch ships with a batch-specific Certificate of Analysis covering identity, purity and content, referenced to the lot number printed on the sachet and vial labels.

Commercial invoice, packing list and Certificate of Analysis are standard. Additional documentation can be prepared according to the import requirements of the destination country.

CoreyPauling laboratory and lyophilization facility

ABOUT COREYPAULING

Science · Innovation · Quality · Trust

CoreyPauling is a US–Singapore based biotechnology company developing and supplying research-grade peptides and proteins to distributors and laboratories worldwide. Grounded in scientific rigour and international manufacturing standards, the brand stands for precision, continuous innovation and long-term reliability.

Liratide™ sits alongside the wider CoreyPauling catalogue — including Somapin™, Bepeci™, Retatride™, Tesamore™, Thymob™, Lorenpickart™, Kaypv™, Menotrope™, Igtrin™, Glutatone™ and Pregnil™ — all supplied under the same documentation and cold-chain standards.

Every batch of Liratide™ is manufactured at the CoreyPauling facility. Full company information, the complete product catalogue and manufacturing capabilities are available on the official factory website at coreypauling.com.

VISIT COREYPAULING.COM

WHOLESALE INQUIRY

Distribute Liratide™

For quotations, batch documentation, certificates of analysis and export terms, contact our wholesale team. Please include your company details, destination country and required quantities.

support@coreypauling.com
For Research and Analytics Only